UK Markets closed

Relief Therapeutics Holding AG (RLFTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.2570+0.0150 (+6.20%)
At close: 3:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.2420
Open0.2400
BidN/A x N/A
AskN/A x N/A
Day's range0.2290 - 0.2575
52-week range0.1820 - 0.7600
Volume4,944,841
Avg. volume4,950,131
Market cap846.604M
Beta (5Y monthly)-22.81
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Relief Reports that its U.S. Collaboration Partner has Announced Emergency Use Authorization of Aviptadil in Nation of Georgia

    EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Regulatory Approval28.07.2021 / 07:15 Relief Reports that its U.S. Collaboration Partner has Announced Emergency Use Authorization of Aviptadil in Nation of GeorgiaGeneva, Switzerland, July 28, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, reported today that the parent company of its col

  • EQS Group

    Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita

    EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Takeover28.07.2021 / 07:00 Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita Acquisition Expands Scope of Development of Inhaled Formulation of AviptadilGeneva, Switzerland, July 28, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today anno

  • EQS Group

    Relief Therapeutics Announces CHF 15 Million Private Placement

    EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Financing26.07.2021 / 07:00 Relief Therapeutics Announces CHF 15 Million Private Placement Geneva, Switzerland, July 26, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the "Company"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need, today announced that it has entered into a definitive agreement with two U.S. institutional investors to